l carnitine safety in pregnancy l-carnitine Pregnancy Is L Carnitine Safe During
Description
doi:10.1038/sj.ejcn.1602188
[DOI] [PubMed] [Google Scholar] 182.Shao L., Martin M.V., Watson S.J., Schatzberg A., Akil H., Myers R.M., Jones E.G., Bunney W.E., Vawter M.P

Abbreviations BP: Blood pressure CI: Confidence interval CIMT: Carotid intima-media thickness eGFR: Estimated glomerular filtration rate HbA1C: Hemoglobin A1c HDL: High-density lipoprotein cholesterol ICA: Internal carotid artery L-C: L-carnitine LDL-C: Low-density lipoprotein cholesterol Lp(a): Lipoprotein (a) MetS: Metabolic syndrome MI: Myocardial infarction MPH: Maximum plaque height NSAIDs: Nonsteroidal anti-inflammatory drugs SAEs: Serious adverse events TMAO: Metabolites such as trimethylamine oxidase TPA: Total plaque area TPV: Total plaque volume WC: Waist circumference References Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al
Consonance with these mechanistic pathways, the results of this review indicate favorable cardiac outcomes with L-carnitine supplementation, including reduced infarct size as well as lower incidence of heart failure, ventricular arrhythmia, total cardiac events, and all-cause mortality
